# International Money Express, Inc.: financial statements, quarterly

IMXI · Nasdaq · CIK 1683695 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imxi.md) · [Financials](/companies/imxi/financials.md) · [Filings](/companies/imxi/filings.md) · [Insiders](/companies/imxi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/imxi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [172](/filings/0001683695-24-000157.md) | [172 d](/filings/0001628280-26-015647.md) | [150](/filings/0001683695-25-000063.md) | [172](/filings/0001683695-25-000100.md) | [172](/filings/0001628280-25-051013.md) | [165 d](/filings/0001628280-26-015647.md) | [144](/filings/0001628280-26-033174.md) | [161](/filings/0001628280-26-055191.md) | [155](/filings/0001628280-25-051013.md) | [147 d](/filings/0001628280-26-015647.md) | [122](/filings/0001628280-26-033174.md) | [131](/filings/0001628280-26-055191.md) |
| Operating income | $m | [24.3](/filings/0001683695-24-000157.md) | [27.7 d](/filings/0001628280-26-015647.md) | [19.6](/filings/0001683695-25-000063.md) | [22.9](/filings/0001683695-25-000100.md) | [27.8](/filings/0001628280-25-051013.md) | [24.7 d](/filings/0001628280-26-015647.md) | [14.1](/filings/0001628280-26-033174.md) | [19.5](/filings/0001628280-26-055191.md) | [10.5](/filings/0001628280-25-051013.md) | [11.6 d](/filings/0001628280-26-015647.md) | [3.7](/filings/0001628280-26-033174.md) | [8.8](/filings/0001628280-26-055191.md) |
| Interest expense | $m | [2.8](/filings/0001683695-23-000069.md) | [2.8 d](/filings/0001683695-24-000042.md) | [2.7](/filings/0001683695-24-000097.md) | [3.1](/filings/0001683695-25-000100.md) | [3.2](/filings/0001628280-25-051013.md) | [2.7 d](/filings/0001628280-26-015647.md) | [2.7](/filings/0001628280-26-033174.md) | [3.1](/filings/0001628280-26-055191.md) | [3.0](/filings/0001628280-25-051013.md) | [3.1 d](/filings/0001628280-26-015647.md) | [2.2](/filings/0001628280-26-033174.md) | [2.3](/filings/0001628280-26-055191.md) |
| Income tax | $m | [6.6](/filings/0001683695-24-000157.md) | [7.4 d](/filings/0001628280-26-015647.md) | [4.8](/filings/0001683695-25-000063.md) | [5.8](/filings/0001683695-25-000100.md) | [7.3](/filings/0001628280-25-051013.md) | [6.6 d](/filings/0001628280-26-015647.md) | [3.6](/filings/0001628280-26-033174.md) | [5.4](/filings/0001628280-26-055191.md) | [2.6](/filings/0001628280-25-051013.md) | [2.9 d](/filings/0001628280-26-015647.md) | [1.0](/filings/0001628280-26-033174.md) | [2.2](/filings/0001628280-26-055191.md) |
| Net income | $m | [14.8](/filings/0001683695-24-000157.md) | [17.5 d](/filings/0001628280-26-015647.md) | [12.1](/filings/0001683695-25-000063.md) | [14.0](/filings/0001683695-25-000100.md) | [17.3](/filings/0001628280-25-051013.md) | [15.4 d](/filings/0001628280-26-015647.md) | [7.8](/filings/0001628280-26-033174.md) | [11.0](/filings/0001628280-26-055191.md) | [5.0](/filings/0001628280-25-051013.md) | [8.9 d](/filings/0001628280-26-015647.md) | [0.5](/filings/0001628280-26-033174.md) | [4.2](/filings/0001628280-26-055191.md) |
| Diluted EPS | $ per share | [0.41](/filings/0001683695-24-000157.md) | not reported | [0.35](/filings/0001683695-25-000063.md) | [0.42](/filings/0001683695-25-000100.md) | [0.53](/filings/0001628280-25-051013.md) | not reported | [0.25](/filings/0001628280-26-033174.md) | [0.37](/filings/0001628280-26-055191.md) | [0.17](/filings/0001628280-25-051013.md) | not reported | [0.02](/filings/0001628280-26-033174.md) | [0.14](/filings/0001628280-26-055191.md) |
| Basic EPS | $ per share | [0.42](/filings/0001683695-24-000157.md) | not reported | [0.36](/filings/0001683695-25-000063.md) | [0.43](/filings/0001683695-25-000100.md) | [0.53](/filings/0001628280-25-051013.md) | not reported | [0.25](/filings/0001628280-26-033174.md) | [0.37](/filings/0001628280-26-055191.md) | [0.17](/filings/0001628280-25-051013.md) | not reported | [0.02](/filings/0001628280-26-033174.md) | [0.14](/filings/0001628280-26-055191.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [222](/filings/0001683695-23-000069.md) | [239](/filings/0001683695-25-000030.md) | [219](/filings/0001683695-24-000097.md) | [233](/filings/0001683695-24-000138.md) | [157](/filings/0001683695-24-000157.md) | [131](/filings/0001628280-26-015647.md) | [152](/filings/0001683695-25-000063.md) | [175](/filings/0001683695-25-000100.md) | [152](/filings/0001628280-25-051013.md) | [169](/filings/0001628280-26-055191.md) | [170](/filings/0001628280-26-033174.md) | [151](/filings/0001628280-26-055191.md) |
| Current assets | $m | [482](/filings/0001683695-23-000069.md) | [433](/filings/0001683695-25-000030.md) | [402](/filings/0001683695-24-000097.md) | [463](/filings/0001683695-24-000138.md) | [326](/filings/0001683695-24-000157.md) | [298](/filings/0001628280-26-015647.md) | [326](/filings/0001683695-25-000063.md) | [351](/filings/0001683695-25-000100.md) | [311](/filings/0001628280-25-051013.md) | [353](/filings/0001628280-26-055191.md) | [402](/filings/0001628280-26-033174.md) | [286](/filings/0001628280-26-055191.md) |
| Total assets | $m | [620](/filings/0001683695-23-000069.md) | [577](/filings/0001683695-25-000030.md) | [549](/filings/0001683695-24-000097.md) | [612](/filings/0001683695-24-000138.md) | [481](/filings/0001683695-24-000157.md) | [462](/filings/0001628280-26-015647.md) | [491](/filings/0001683695-25-000063.md) | [518](/filings/0001683695-25-000100.md) | [479](/filings/0001628280-25-051013.md) | [518](/filings/0001628280-26-055191.md) | [566](/filings/0001628280-26-033174.md) | [450](/filings/0001628280-26-055191.md) |
| Current liabilities | $m | [244](/filings/0001683695-23-000069.md) | [223](/filings/0001683695-25-000030.md) | [239](/filings/0001683695-24-000097.md) | [246](/filings/0001683695-24-000138.md) | [181](/filings/0001683695-24-000157.md) | [152](/filings/0001628280-26-015647.md) | [186](/filings/0001683695-25-000063.md) | [215](/filings/0001683695-25-000100.md) | [154](/filings/0001628280-25-051013.md) | [141](/filings/0001628280-26-055191.md) | [142](/filings/0001628280-26-033174.md) | [146](/filings/0001628280-26-055191.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | [193](/filings/0001683695-23-000069.md) | [181](/filings/0001683695-25-000030.md) | [151](/filings/0001683695-24-000097.md) | [203](/filings/0001683695-24-000138.md) | [138](/filings/0001683695-24-000157.md) | [157](/filings/0001628280-26-015647.md) | [147](/filings/0001683695-25-000063.md) | [144](/filings/0001683695-25-000100.md) | [158](/filings/0001628280-25-051013.md) | [195](/filings/0001628280-26-055191.md) | [241](/filings/0001628280-26-033174.md) | [114](/filings/0001628280-26-055191.md) |
| Current portion of debt | $m | [6.6](/filings/0001683695-23-000069.md) | [7.2](/filings/0001683695-25-000030.md) | [7.7](/filings/0001683695-24-000097.md) | [8.3](/filings/0001683695-24-000138.md) | [0.0](/filings/0001683695-24-000157.md) | [0.0](/filings/0001683695-25-000030.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [158](/filings/0001683695-24-000157.md) | [149](/filings/0001628280-26-015647.md) | [138](/filings/0001683695-25-000100.md) | [142](/filings/0001628280-25-051013.md) | [142](/filings/0001628280-25-051013.md) | [135](/filings/0001628280-26-055191.md) | [139](/filings/0001628280-26-055191.md) | [142](/filings/0001628280-26-055191.md) | [150](/filings/0001628280-25-051013.md) | [161](/filings/0001628280-26-055191.md) | [163](/filings/0001628280-26-055191.md) | [170](/filings/0001628280-26-055191.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [82.4 d](/filings/0001683695-24-000157.md) | [61.1 d](/filings/0001628280-26-015647.md) | [48.2](/filings/0001683695-25-000063.md) | [(19.6) d](/filings/0001683695-25-000100.md) | [29.3 d](/filings/0001628280-25-051013.md) | [(4.9) d](/filings/0001628280-26-015647.md) | [41.3](/filings/0001628280-26-033174.md) | [39.9 d](/filings/0001628280-26-055191.md) | [(28.7) d](/filings/0001628280-25-051013.md) | [(15.6) d](/filings/0001628280-26-015647.md) | [(37.4)](/filings/0001628280-26-033174.md) | [113 d](/filings/0001628280-26-055191.md) |
| Capital expenditure | $m | [3.2 d](/filings/0001683695-24-000157.md) | [5.1 d](/filings/0001628280-26-015647.md) | [13.5](/filings/0001683695-25-000063.md) | [6.7 d](/filings/0001683695-25-000100.md) | [5.9 d](/filings/0001628280-25-051013.md) | [3.9 d](/filings/0001628280-26-015647.md) | [5.3](/filings/0001628280-26-033174.md) | [4.6 d](/filings/0001628280-26-055191.md) | [6.9 d](/filings/0001628280-25-051013.md) | [4.4 d](/filings/0001628280-26-015647.md) | [5.5](/filings/0001628280-26-033174.md) | [5.5 d](/filings/0001628280-26-055191.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [10.1 d](/filings/0001683695-24-000157.md) | [25.6 d](/filings/0001628280-26-015647.md) | [23.4](/filings/0001683695-25-000063.md) | [11.2 d](/filings/0001683695-25-000100.md) | [20.3 d](/filings/0001628280-25-051013.md) | [20.2 d](/filings/0001628280-26-015647.md) | [5.0](/filings/0001628280-26-033174.md) | [11.4 d](/filings/0001628280-26-055191.md) | [0.0 d](/filings/0001628280-25-051013.md) | [0.0 d](/filings/0001628280-26-015647.md) | [0.0](/filings/0001628280-26-033174.md) | [0.0 d](/filings/0001628280-26-055191.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [38.4](/filings/0001683695-23-000069.md) | [37.4](/filings/0001683695-24-000097.md) | [36.9](/filings/0001683695-24-000138.md) | [36.1](/filings/0001683695-24-000157.md) | [34.2](/filings/0001683695-25-000063.md) | [33.1](/filings/0001683695-25-000100.md) | [32.7](/filings/0001628280-25-051013.md) | [30.8](/filings/0001628280-26-033174.md) | [29.9](/filings/0001628280-26-055191.md) | [29.8](/filings/0001628280-25-051013.md) | [30.4](/filings/0001628280-26-033174.md) | [30.6](/filings/0001628280-26-055191.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,211,627 at 2026-08-03, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055191.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.